Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Removing GRK2 in skin cells causes hair loss similar to immune-related alopecia.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

The study created a mouse model that survives longer and shows fewer symptoms of pemphigus vulgaris.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

The engineered skin substitute helped grow skin with hair on mice.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Semaglutide may help some skin disorders but can also cause skin issues.

Blocking DKK1 with siRNA can improve hair growth.

Ginsenoside Rg3 may help hair growth by increasing a growth-related protein in hair cells.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.

PGD2 stops hair growth and is higher in bald men with AGA.

A new DSG4 gene mutation causes hair defects in a young girl.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Panax notoginseng saponins with stem cells improve healing and reduce inflammation in diabetic ulcers.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.